Generated by AI
AstraZeneca PLC American Depositary Shares represent ownership in AstraZeneca PLC, a global biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. AstraZeneca’s current business spans Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. The company develops and markets treatments used across hospitals, clinics, and specialty care settings, serving patients and healthcare providers in major therapeutic areas with high unmet medical need. Its portfolio is built around branded medicines and regulated drug launches, with ongoing commercial activity across the United States, Europe, and other international markets. AstraZeneca PLC American Depositary Shares provide U.S. investors a way to hold an instrument linked to the company’s underlying shares while participating in the performance of one of the world’s largest research-driven drugmakers.
Website1 Francis Crick Avenue
Cambridge, CB2 0AA
United Kingdom
The latest articles about AZN.
Rhythm Pharma's Imcivree generated $92.1 million in Q3; its estimated $8.25 billion market cap exceeds 20 times estimated 2026 revenue. I rate RYTM stock as Hold.
Summary of Nov 16's posts. Generated by AI.
Summary of Oct 30's posts. Generated by AI.
Summary of Oct 22's posts. Generated by AI.
Summary of Nov 16's posts. Generated by AI.
Investors talking about AZN also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.